Attached files
file | filename |
---|---|
10-Q - Emmaus Life Sciences, Inc. | v211191_10q.htm |
EX-31.1 - Emmaus Life Sciences, Inc. | v211191_ex31-1.htm |
EX-31.2 - Emmaus Life Sciences, Inc. | v211191_ex31-2.htm |
EXHIBIT
32.1
CERTIFICATION
PURSUANT TO
18 U.S.C.
SECTION 1350
AS
ADOPTED PURSUANT TO
SECTION
906 OF THE SARBANES-OXLEY ACT OF 2002
Pursuant
to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the
Sarbanes-Oxley Act of 2002, in connection with the filing of the Quarterly
Report on Form 10-Q for the quarter ended December 31, 2010 (the “Report”) by
CNS Response, Inc. (the “Registrant”), the undersigned hereby certifies that to
the best of his knowledge:
|
1.
|
the
Report fully complies with the requirements of section 13(a) or 15(d) of
the Securities Exchange Act of 1934;
and
|
|
2.
|
the
information contained in the Report fairly presents, in all material
respects, the financial condition and results of operations of the
Registrant.
|
Date: February
14, 2010
|
/s/ George Carpenter | |
George
Carpenter
|
||
Chief
Executive Officer (Principal Executive Officer)
|
||
/s/ Paul Buck | ||
Paul
Buck
|
||
Chief
Financial Officer (Principal Financial Officer)
|